“…Especially in the first year after HTx, patients suffer from chronic tachycardia, with resting heart rates (HRs) elevated to greater than 90 beats/min (bpm) and significantly reduced HR variability (HRV) (Awad et al, 2016;Kobashigawa and Olymbios, 2017). Furthermore, on top of raised HR recovery times, HTx recipients (HTxRs) show delayed and impeded exercise response (Awad et al, 2016;Kobashigawa and Olymbios, 2017), reaching peak HRs as low as only 133 bpm (McLaughlin et al, 1978;Crisafulli et al, 1985;Kavanagh et al, 1988;Labovitz et al, 1989;Wilson et al, 1991;Marzo et al, 1992;Rudas et al, 1993;Kao et al, 1994;Doering et al, 1996;Geny et al, 1996;Notarius et al, 1998;Hayman et al, 2010;Peled et al, 2017;Nygaard et al, 2019;Nytrøen et al, 2019). According to literature, elevated resting HRs are most certainly a result of the absence of vagal tone, rendering the heart to rely on intrinsic control only, whereas delayed and impeded exercise response is most likely due to lack of vagal withdrawal and missing sympathetic drive (Awad et al, 2016).…”